This was the stock's second consecutive day of gains.
12h
Application segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 8%. The AISS (Clinical) Application ...
Piper Sandler analyst Adam Maeder maintained a Buy rating on Inspire Medical Systems (INSP – Research Report) today and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback